Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...

It is one of the top four types of cancer in the UK and symptoms are often hard to detect in the early stages, but spotting these sensations may be signs to get treatment ...

Incorporating biomarkers into standard practice enhances diagnostic accuracy, supporting confident treatment decisions and optimizing care.

The rising incidence of prostate cancer in Nigeria, as highlighted in a recent report, underscores a critical public health challenge.

OncoAssure Ltd, an Irish medical diagnostic company, today announced the publication of new data, in the British Journal of Urology International Compass (BJUI Compass), which demonstrates the ...

Learn how an enlarged prostate and Parkinsonism can overlap, impact daily life, and be managed effectively for better health.

A new test for prostate cancer developed by Irish and Swedish researchers better predicts the risks of the aggressive disease ...

OncoAssure's new data demonstrates that its biopsy test provides an 'improved estimation' of a patient’s risk of prostate ...

Physicians in the field of urology have advised men, particularly those of African descent to stop attributing the cause of ...

Prostate cancer is rapidly emerging as a significant health challenge in China, with the incidence rate steadily rising.

“There's a lot of sugar, fat, and salt, preservatives…and other chemical compounds [in a typical American diet],” says ...